Credit Suisse’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4.74M | Sell |
|
|||||
|
2023
Q4 | $5.12M | Sell |
|
|||||
|
2023
Q3 | $3.31M | Sell |
|
|||||
|
2023
Q2 | $8.55M | Buy |
|
|||||
|
2023
Q1 | $5.54M | Buy |
|
|||||
|
2022
Q4 | $3.98M | Buy |
|
|||||
|
2022
Q3 | $5.25M | Buy |
|
|||||
|
2022
Q2 | $2.93M | Sell |
|
|||||
|
2022
Q1 | $3.57M | Buy |
|
|||||
|
2021
Q4 | $2.98M | Buy |
|
|||||
|
2021
Q3 | $1.95M | Buy |
|
|||||
|
2021
Q2 | $2.89M | Sell |
|
|||||
|
2021
Q1 | $2.07M | Sell |
|
|||||
|
2020
Q4 | $5.18M | Sell |
|
|||||
|
2020
Q3 | $3.18M | Sell |
|
|||||
|
2020
Q2 | $4.17M | Buy |
|
|||||
|
2020
Q1 | $1.46M | Sell |
|
|||||
|
2019
Q4 | $1.85M | Buy |
|
|||||
|
2019
Q3 | $1.24M | Buy |
|
|||||
|
2019
Q2 | $728K | Buy |
|
|||||
|
2019
Q1 | $464K | Buy |
|
|||||
|
2018
Q4 | $258K | Buy |
|
|||||
|
2018
Q3 | $241K | Sell |
|
|||||
|
2018
Q2 | $320K | Buy |
|